Horizon Pharma PLC Executives
| HZNPDelisted Stock | USD 100.40 0.13 0.13% |
Horizon Pharma employs about 2.2 K people. The company is managed by 10 executives with a total tenure of roughly 40 years, averaging almost 4.0 years of service per executive, having 219.0 employees per reported executive. Discussion of Horizon Pharma's management performance can provide insight into the enterprise performance.
| Timothy Walbert Chairman Chairman, CEO and Pres |
| Geoffrey Curtis President Senior Vice President - Corporate Communications |
Horizon |
Horizon Pharma's latest congressional trading
Congressional trading in companies like Horizon Pharma PLC, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Horizon Pharma by those in governmental positions are based on the same information available to the general public.
| 2024-08-14 | Representative Greg Landsman | Acquired Under $15K | Verify |
Horizon Pharma Management Team Effectiveness
The company has return on total asset (ROA) of 0.0444 % which means that it generated a profit of $0.0444 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0854 %, meaning that it created $0.0854 on every $100 dollars invested by stockholders. Horizon Pharma's management efficiency ratios could be used to measure how well Horizon Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Horizon Pharma Workforce Comparison
Horizon Pharma PLC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 801,760. Horizon Pharma adds roughly 2,190 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18. Horizon Pharma Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Horizon Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Horizon Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Horizon Pharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Thomas Watkins over a year ago Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3 | ||
Thomas Watkins over a year ago Exercise or conversion by Thomas Watkins of 40000 shares of Horizon Pharma subject to Rule 16b-3 | ||
Thomas Watkins over a year ago Exercise or conversion by Thomas Watkins of 4223 shares of Horizon Pharma subject to Rule 16b-3 |
Horizon Pharma Notable Stakeholders
A Horizon Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Horizon Pharma often face trade-offs trying to please all of them. Horizon Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Horizon Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Timothy Walbert | Chairman, CEO and Pres | Profile | |
| Tina Ventura | Senior Vice President Investor Relations | Profile | |
| Geoffrey Curtis | Senior Vice President - Corporate Communications | Profile | |
| Paul Hoelscher | CFO and Executive VP of Fin. | Profile | |
| Jane Gonnerman | Office Staff | Profile | |
| Sean JD | Exec Counsel | Profile | |
| Patrick McIlvenny | VP Officer | Profile | |
| FACP FACP | Ex Officer | Profile | |
| Andy Pasternak | Ex Officer | Profile | |
| Aaron Cox | Exec CFO | Profile |
About Horizon Pharma Management Performance
The success or failure of an entity such as Horizon Pharma PLC often depends on how effective the management is. Horizon Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Horizon management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Horizon management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois Chicago, Illinois Lake Forest, Illinois South San Francisco, California Washington, D.C. Gaithersburg, Maryland Rockville, Maryland and Mannheim, Germany. Horizon Therapeutics is traded on NASDAQ Exchange in the United States.
Horizon Pharma Workforce Analysis
Traditionally, organizations such as Horizon Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Horizon Pharma within its industry.Horizon Pharma Manpower Efficiency
Return on Horizon Pharma Manpower
| Revenue Per Employee | 1.7M | |
| Revenue Per Executive | 362.9M | |
| Net Income Per Employee | 238.1K | |
| Net Income Per Executive | 52.1M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 270.4M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Horizon Stock
If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |